Psoriatic Alopecia And Paradoxical Psoriasis Induced By Adalimumab Successfully Treated With Certolizumab: Clinical, Trichoscopic, And In Vivo Reflectance Confocal Microscopy Features
December 2022
in “
Skin Appendage Disorders
”
Certolizumab was found to be an effective and safe alternative for managing psoriasis and psoriatic arthritis (PsA), particularly in minimizing the risk of paradoxical reactions such as psoriatic alopecia, compared to other anti-TNF-α agents like adalimumab.